NANOVIRICIDES, INC. — Director's Dealing 2013

Oct 24, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2013-10-22

Reporting Person: Diwan Anil (Director, President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-21	Common Stock	S	142000	$5.29	Disposed	1824286	Direct

Footnotes

F1: Includes 1,680,629 shares of common stock, 285,714 shares issuable upon exercise of options. Does not include 285,714 shares of the Company's Series A Convertible Preferred Stock ("Series A") or 9,531,429 shares of common stock and 2,000,000 shares of Series A owned by TheraCour Pharma, Inc., over which Dr. Diwan holds voting and dispositive power.